The Houses of Parliament and Elizabeth Tower beside the Thames at dusk

Global Vaccine Leadership Summit 2027

London, 20 May 2027 — Global Vaccine Leadership Summit 2027

Hilton London Olympia, United Kingdom

Co-located with Pharmacovigilance Europe 2027 www.pveurope.com

People. Partnerships. Progress.

01 About this edition

The London edition.

On 20 May 2027, the Global Vaccine Leadership Summit convenes in London as one of two global editions — an invitation-led gathering organised by Graviton International.

The London edition is co-located with Pharmacovigilance Europe 2027 (www.pveurope.com) at Hilton London Olympia.

In a single, focused day, the London edition examines the priorities shaping vaccines today: scientific innovation and development, regulation and vaccine safety, pandemic preparedness, and equitable access and delivery. Sessions connect research, policy and industry perspectives, with an emphasis on decisions and practical next steps.

The day is designed for senior leaders from industry, government, regulators, public health, academia and biotechnology. Delegates can expect keynotes, leadership discussions and panels, with time built in for the one-to-one conversations that matter between sessions.

02 Why attend

A room built for consequential conversations.

A closed-door, invitation-led format, with the time and space for exchange that larger congresses cannot offer.

  • Global Leadership

    Senior leaders from across sectors, convened at a scale that allows genuine exchange.

  • Strategic Connections

    An invitation-led delegation, so the people you meet are the people you need to meet.

  • Cross-Sector Dialogue

    Government, academia, industry and global health in the same conversation.

  • Scientific Insight

    Sessions grounded in the science shaping vaccine innovation and preparedness.

  • International Partnerships

    A forum linked to its sister edition, building relationships across continents.

  • Focused Networking

    Structured time between sessions for the conversations that move work forward.

03 Programme

A day of leadership, dialogue and connection.

Thursday20 May 2027

Indicative structure Session times and titles are placeholders and will change.

  1. Registration & Networking
  2. Opening Remarks
  3. Opening Keynote
  4. Leadership Discussion
  5. Networking Break
  6. Strategic Panel
  7. Networking Lunch
  8. Afternoon Sessions
  9. Networking Break
  10. Leadership Forum
  11. Closing Discussion

Full programme coming soon.

04 Speakers

The voices shaping the conversation.

Chaired by Dr Bassam Hallis OBE of the UK Health Security Agency, with speakers from the UK and India confirmed. Further speakers will be announced as they are confirmed.

  • Portrait of Dr Bassam Hallis OBE

    Summit Chair

    Dr Bassam Hallis OBE

    Deputy Director, Head of Vaccine Development & Evaluation Centre, UK Health Security Agency

    United Kingdom

    Biography

    Dr Bassam Hallis OBE is Deputy Director and lead for the Vaccine Development and Evaluation Centre at the UK Health Security Agency.

    Bassam has over 35 years’ experience working with the public sector, industry and academia in the development and evaluation of vaccines and therapeutics. He provides scientific and operational leadership in the evaluation of immunogenicity and efficacy of vaccines and therapeutics for high-consequence infectious diseases, including influenza and COVID-19. His research and expertise span the life cycle of countermeasures, from early-stage antigen discovery to post-licensure, and incorporate in vitro and in vivo activities at containment levels 2, 3 and 4.

    Bassam collaborates across academia, industry and the not-for-profit sector to develop pandemic preparedness capabilities, and supports the development of scientific capabilities globally, especially in the Global South.

  • Portrait of Prof. Saul Faust

    Prof. Saul Faust

    Professor of Paediatric Immunology and Infectious Diseases, NIHR

    United Kingdom

    Biography

    Professor Saul Faust is an NIHR Senior Investigator and Co-National Specialty Lead for Children, and Professor of Paediatric Immunology and Infectious Diseases. His research focuses on clinical trials of vaccines and antimicrobials in children and adults. He is Director of the NIHR Southampton Clinical Research Facility, Co-Director of the NIHR Wessex Commercial Research Delivery Centre, National Co-Clinical Lead for Infection Vaccines in the NIHR Vaccine Innovation Pathway, and NIHR RDN South Central Co-Health and Care Director (Medical).

  • Dr. Mohanish Vaidya

    Head Medico Marketing, International Business Division, Serum Institute of India

    India

    Biography

    Dr. Mohanish Vaidya is Head of Medico Marketing for the International Business Division at Serum Institute of India Pvt. Ltd., based in Pune, Maharashtra.

  • To be announced

  • To be announced

  • To be announced

  • To be announced

  • To be announced

Senior leaders in discussion around a table

05 Exhibition & partnership

Partner with global vaccine leadership.

Four levels of partnership, each designed around meaningful access rather than volume.

Partnership levels and benefits. All benefits to be confirmed.
BenefitsIHeadline PartnerIIGold PartnerIIISilver PartnerIVExhibition Partner
Brand visibilityTo be confirmedTo be confirmedTo be confirmedTo be confirmed
Delegate accessTo be confirmedTo be confirmedTo be confirmedTo be confirmed
Exhibition presenceTo be confirmedTo be confirmedTo be confirmedTo be confirmed
Thought-leadership opportunitiesTo be confirmedTo be confirmedTo be confirmedTo be confirmed
NetworkingTo be confirmedTo be confirmedTo be confirmedTo be confirmed
Digital visibilityTo be confirmedTo be confirmedTo be confirmedTo be confirmed

Benefits are being finalised. The prospectus sets out full details for each level.

Request the partnership prospectus

06 Delegate passes

Join the conversation.

One delegate rate for everyone — the earlier you book, the less you pay. Prices exclude VAT.

Special Offer

Ends 30 November 2026

  • ––Days
  • ––Hours
  • ––Mins
  • ––Secs

Stage 01

Special Offer

£499+ VAT

Book by 30 November 2026

Stage 02

Super Early Bird

£699+ VAT

Book by 31 January 2027

Stage 03

Early Bird

£799+ VAT

Book by 31 March 2027

Stage 04

Standard

£999+ VAT

From 1 April 2027

All prices are per delegate and exclude VAT at 20%. Places are limited.

Book your pass

07 Travel & stay

Plan your visit.

Venue

Hilton London Olympia

Address
380 Kensington High Street, London W14 8NL, United Kingdom
Nearest airport
London Heathrow (LHR)
Local transport
Nearest station: Kensington (Olympia)
Accommodation
Compare and book hotels near the venue on the hotel map
Visa guidance
Check whether you need a visa at GOV.UK
Get directions

Where to stay

Hotels near the venue

Open the hotel map

Listing not showing? Open the hotel map in a new tab.

Also joining us in Boston?

Boston

15–16 September 2027

Explore Boston

Brochure

Request the brochure.

The delegate brochure and partnership prospectus for the London edition. Complete a short form and the brochure will be sent to you.

Request the brochure (opens in a new tab)

Opens a short Google Form in a new tab.

#GVLS2027

Register your interest

The summit is invitation-led. Share a few details and the Graviton International team will follow up.

I'm interested in